HOPE-Genomics Intervention for the Improvement of Cancer Patient Knowledge of Genomics

Part of paid clinical trials in Duarte, California.

Sponsor
City of Hope Medical Center
Study ID
NCT04905082
Status
Active Not Recruiting

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Best Practice — OTHER
    Receive usual care
  • Educational Intervention — OTHER
    View HOPE-Genomics tool after genomic test results are available
  • Educational Intervention — OTHER
    View HOPE-Genomics before sequencing results are available
  • Genomic Profile — PROCEDURE
    Receive genomics test results
  • Survey Administration — OTHER
    Ancillary studies

Study Details

This clinical trial studies the effectiveness of a web-based cancer education tool called Helping Oncology Patients Explore Genomics (HOPE-Genomics) in improving patient knowledge of personal genomic testing results and cancer and genomics in general. HOPE-Genomics is a web-based education tool that teaches cancer/leukemia patients, and patients who may be at high-risk for developing cancer, about genomic testing and provide patients with information about their own genomic test results. The HOPE-Genomics tool may improve patient's genomic knowledge and quality of patient-centered care. In addition, it may also improve education and care quality for future patients.

Key Dates

Start date
Dec 30, 2021
Status verified
Mar 2026
Primary completion
Aug 14, 2024
Completion
Jun 15, 2026

Study Design

Enrollment
465 participants (actual)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE

Arms

  • Active Comparator: Arm I (usual care)
    Patients receive education pamphlet about WES and have their genomics test results returned by their clinician in a typical manner.
  • Experimental: Arm II (genomics test results, HOPE-Genomics)
    Patients receive their genomics test results both from their clinician and from the HOPE-Genomics tool. Patients then view HOPE-Genomics tool over 15-20 minutes after their results are available.
  • Experimental: Arm III (HOPE-Genomics, genomics test results)
    Patients view HOPE-Genomics tool (containing educational content) over 15-20 minutes before their sequencing results are available. Patients also receive their genomics test results both from their clinician and from the HOPE-Genomics tool.

Primary Outcome Measure

Recall Rates of Personal Genomic Results [ Time Frame: Up to 3 months ]

Locations (1)

FacilityCityStateZIPSite coordinators
City of Hope Medical CenterDuarteCalifornia91010-

Find similar trials in Duarte, CA

By condition
Breast cancerColorectal cancerLung cancerOvarian cancerPancreatic cancerProstate cancer
By specialty
OncologyBreast oncologyWomen's healthGI oncologyLung oncologyLung diseaseGynecologic oncologyProstate oncologyMen's healthUrology
By research site
City of Hope Medical Center· Duarte, CA

Related Studies